Enhancement of Osteogenic Induction by LL37 Modified with a Collagen-Binding Domain in Vitro and in Vivo

Lin Xiaoxuan,Chen Sipeng,Quan Jingjing,Zhang Qi,Liao Muzi,Ma Xinyue,Zheng Yuyan,Mai Sui
DOI: https://doi.org/10.1007/s10989-021-10216-w
2021-01-01
International Journal of Peptide Research and Therapeutics
Abstract:Bone defect diseases, particularly those induced by inflammation, pose a challenge for the design of ideal drug-loading scaffolds that could facilitate bone repair and eliminate inflammatory pathogens. Antimicrobial peptides LL37 is considered a promising alternative loading drug due to its broad-spectrum antimicrobial effect and various bio-functions, including osteogenic induction. In this study, we synthesized modified LL37 by adding a collagen-binding domain (CBD) to achieve specific binding to collagen and a slow release pattern. The modified peptide was indicated to exhibit similar biological activities as natural LL37 on rat BMSCs, including promotion of migration activity, anti-inflammatory activity and osteogenic induction in vitro. Ectopic bone formation experiments further confirmed the angiogenesis and osteoinduction activities in vivo. Collectively, the results indicate that LL37-CBD may be a potential loading drug for preventative and curative applications in the treatment of inflammation-induced bone diseases.
What problem does this paper attempt to address?